Turkish President Erdogan has threatened to take action against Moody’s after June 24 elections, his latest broadside against credit rating agencies that he says are trying to bring down the economy.
Fitch Ratings today raised India growth forecast for 2018-19 to 7.4 per cent from 7.3 per cent, but cited higher financing costs and rising oil prices as risks to growth.
Punjab National Bank (PNB) said Moody's Investors Service has upgraded Counterparty Risk Rating (CRR) to Baa3 from Ba1 following the bank's strong recovery and the government's continued support.
Global ratings agency Moody's Investors Service today gave counterparty risk ratings (CRR) to 15 lenders in the country, including fraud-hit Punjab National Bank and country's largest lender SBI.
Moody's said the govt's recapitalisation plan for 21 state-run banks will help them in meeting regulatory capital needs, but will be insufficient to support credit growth.
Moody's Investors Service today said it expects India to stick to the estimated fiscal deficit of 3.3 per cent of GDP and even cut capital expenditure to offset any slippage from the budgeted target.
Markets regulator Sebi today allowed credit rating agencies to withdraw the ratings assigned to a financial instrument and provide reason for such a move.
China’s economic restructuring is picking up pace, with its manufacturing sector showing signs of a shift to higher value-added areas - a credit positive, analysts at Moody’s Investors Service said.
"The permanent closure of Vedanta's copper operations is credit negative because it will reduce the company's scale and biz diversity," Moody's said.
Reforms such as GST and demonetisation will improve tax collection and broaden the tax base in India overtime, Moody's said.
U.P. Govt cancels Purvanchal Expressway bids
Co's Rs 1,740 Cr bid for expressway section cancelled
U.P. Govt to re-invite bids for expressway project
Settles Abraxane patent dispute with Celgene Corp
Partner Apotex may sell generic of Abraxane in U.S.
Telecom Department may clear Vodafone-Idea merger today
Dr. Reddys new drug hits legal hurdle
U.S. court issues restraint order following patent litigation over Suboxone
Company remains confident in its legal positions on this patent Court order does not include a prohibition on commercial manufacturing of the product
The court has scheduled an expedited hearing of the preliminary injunction for June 28 Ruling is expected soon thereafter
Board mulls reshuffle of top management
ICICI Prudential Life Chief Bakshi may be named ICICI bank interim